Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00537550
Other study ID # LAL2000
Secondary ID
Status Completed
Phase N/A
First received September 27, 2007
Last updated September 28, 2007
Start date July 2000
Est. completion date June 2006

Study information

Verified date September 2007
Source Gruppo Italiano Malattie EMatologiche dell'Adulto
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The present study has been designed to give participating centers the possibility of better understanding the diagnostic and prognostic factors of ALL patients.


Recruitment information / eligibility

Status Completed
Enrollment 0
Est. completion date June 2006
Est. primary completion date
Accepts healthy volunteers No
Gender All
Age group 14 Years to 60 Years
Eligibility Inclusion Criteria:

- Diagnosis of acute lymphoblastic leukemia (ALL)

- Negative myeloperoxidase stain

- Phenotype T (ALL-T) and B(ALL-B)

Exclusion Criteria:

- Creatinine > 2.5mg/dL after adequate hydratation

- LVEF <50%

- Presence of documented infections not responding to antibiotic and/or antifungal therapy

- Presence of concomitant malignant diseases

- Absence of any psychological condition that does not allow to intake high doses of cortisone

- Patients who have received any antineoplastic chemiotherapy for more than 5 days

- Patients who have received any steroids for more than 10 days

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Vincristine
Steroids pre-treatment
Vincristin, Daunorubicine, Asparaginase, Methotrexate
Induction therapy

Locations

Country Name City State
Italy Az. Ospedaliera S. G. Moscati Avellino
Italy Ist.Ematologia e Oncologia Medica L.e A. Seragnoli Bologna
Italy Ospedale Reg. A di Summa Brindisi
Italy Istituto di Ematologia- Ospedale San Carlo Potenza
Italy Policlinico G.B. Rossi Verona

Sponsors (1)

Lead Sponsor Collaborator
Gruppo Italiano Malattie EMatologiche dell'Adulto

Country where clinical trial is conducted

Italy, 

See also
  Status Clinical Trial Phase
Terminated NCT00393380 - Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor Phase 2
Terminated NCT00313053 - Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia Phase 1
Completed NCT00483132 - Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III Phase 3
Recruiting NCT04940468 - High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology N/A
Terminated NCT00176930 - Stem Cell Transplant for Hematological Malignancy N/A
Completed NCT00406393 - Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) Phase 3
Completed NCT01078337 - T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis N/A
Completed NCT00246662 - Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies Phase 1
Terminated NCT01100658 - Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors N/A
Terminated NCT00185523 - Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML) Phase 2
Completed NCT00905034 - Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage Phase 2
Recruiting NCT00526084 - Functional Pharmacogenomics of Childhood Acute Lymphoblastic Leukemia in Taiwan N/A
Completed NCT00005892 - Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia N/A
Recruiting NCT03544021 - CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) Phase 1/Phase 2
Terminated NCT00176839 - Stem Cell Transplantation for Hematological Malignancies Phase 2/Phase 3
Not yet recruiting NCT05565105 - CD34+ Transplants for Leukemia and Lymphoma Phase 2
Not yet recruiting NCT05154474 - Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
Terminated NCT00907517 - Study of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247) Phase 1
Terminated NCT01050946 - Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit Phase 2
Terminated NCT00167180 - Post Transplant Donor Lymphocyte Infusion Phase 2